other material
confidence high
sentiment neutral
materiality 0.25
Mangoceuticals reports Series B Preferred conversions into 287,467 common shares
MANGOCEUTICALS, INC.
- Three holders converted 392 Series B Preferred shares (aggregate stated value $431,200) at $1.50/share.
- Total common shares issued: 287,467, diluting existing shareholders per preferred terms.
- Exemption claimed under Securities Act Section 3(a)(9) for exchange with existing holders.